OHSU

IRB #

IRB00010178

Title

The Safety and Effectiveness of the VaricElla zosteR VaccinE (VERVE) in Anti-TNF Users Trial

Principal Investigator

Kevin Winthrop

Study Purpose

To evaluate the safety of the Zoster Vaccine in patients using Anti-TNF Therapies

Medical Condition(s)

protection against shingles in individuals with rheumatoid arthritis

Eligibility Criteria

50 years or older
have rheumatoid arthritis
currently recieving an Anti-TNF therapy

Age Range

50 - 95

Healthy Volunteers Needed

No

Duration of Participation

up to 7 weeks

Minors Included

No

Contact

Jennifer Ku 503 494 1384

Sponsor

American College of Rheumatology

Recruitment End

Compensation Provided

Yes

Compensation

You will receive $ 25 for completing the screening visit and $75 for six-week follow up visit. If you withdraw before the end of the study, you will be paid for the visits you have completed. If you complete the entire study, you will receive $100.


Go Back